期刊文献+

ApoE基因对亨廷顿病发病年龄的影响 被引量:2

The impact of apolipoprotein E genotype on age at onset in Huntington disease
下载PDF
导出
摘要 目的探讨ApoE基因对亨廷顿病发病年龄的影响。方法采用PCR-RFLP和非变性聚丙烯酰胺凝胶电泳方法检测29例HD患者的ApoE基因型,分析ApoE基因型与HD发病年龄的关系。结果 HD患者和正常人的ApoE基因型分布无明显差异(χ2=0.730,P>0.05),ε3/4基因型患者的发病年龄[(35.50±5.73)岁]较ε3/3基因型患者[(47.95±10.67)岁]提前(t=0.126,P<0.05),两组的致病CAG重复次数无明显差异[(47.62±4.37)次,(45.26±3.21)次;t=0.227,P>0.05]。结论 ApoE基因型影响HD的发病年龄,ε4等位基因使HD的发病年龄提前。 Objective To detect the impact of apolipoprotein E (ApoE) genotype on age at onset in Huntington disease (HD). Methods PCR amplification and restriction fragment length polymorphism were used to detect ApoE genotypes. Results Genotypes of ApoE were same in HD patients and control group (χ^2=0.730,P〈0.05). The patients carrying genotype epsilon 3/4(35.50±5.73) had an earlier onset than those carrying genotype epsilon 3/3(47.95±10.67,t=0.126,P〈0.05). The difference was not found in CAG repeat between two groups(t=0.227,P〈0.05). Conclusion Allele epsilon 4 gene is an important risk for the development of HD,and may cause its early onset.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2010年第7期615-617,共3页 Journal of Apoplexy and Nervous Diseases
关键词 亨廷顿病 APOE CAG重复 基因多态性 发病年龄 Huntington disease ApoE CAG repeat Genetic polymorphism Age of onset
  • 相关文献

参考文献14

  • 1王育新,张本恕.IT15基因CAG重复次数与亨廷顿病临床表型的相关性[J].中华神经科杂志,2007,40(8):533-535. 被引量:5
  • 2Brecht WJ, Harris FM, Chang S, et al. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice [ J ]. J Neurosci,2004 ,24 :2527-2534.
  • 3Camicioli R, Kaye J, Payami H, et al. Apolipoprotein E epsilon 4 is associated with neuronal loss in the substantia nigra in Alzheimer' s disease[ J]. Dement Geriatr Cogn Disord, 1999,10:437-441.
  • 4Sando SB, Melquist S, Cannon A, et al. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer' s disease:a case control study from central Norway[J]. BMC Neurol,2008 ,8 :9.
  • 5Kalman J, Juhasz A, Majtenyi K, et al. Apolipoprotein E polymorphism in Pick' s disease and in Huntington' s disease[ J]. Neurobiol Aging,2000,21:555-558.
  • 6Pankratz N, Byder L, Halter C, et al. Presence of an APOE4 allele results in significantly earlier onset of Parkinson' s disease and a higher risk with dementia[J]. Mov Disord,2006,21:45-49.
  • 7Schiefermeier M, Kollepper H, Madl C, et al. The impact of apolipoprotein E genotype on age at onset of symptoms and phenotypic expression in Wilson' s disease[ J]. Brain,2000,123:585-590.
  • 8Li Y J, Pericak-Vance MA, Haines JL, et al. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis[ J]. Neurogenetics ,2004,5:209-213.
  • 9Chapman J, Korczyn AD, Karussis DM, et al. The effects of APOE on age at onset and progression of neurodegenerative disease [ J ]. Neurology ,2001,57 : 1482-1485.
  • 10Feigin A,Tang C, Ma Y, et al. Thalamic metabolism and symptom onset in preclinical Huntington' s disease [ J ]. Brain,2007,130 ( Pt 11 ) :2858-2867.

二级参考文献12

  • 1莫亚勤,李麓芸,卢光琇.亨廷顿病的基因诊断[J].遗传,2005,27(6):861-864. 被引量:3
  • 2Unified Huntington' s disease rating scale: reliability and consistency. Mov Disord, 1996, 11: 136-142.
  • 3Raskin S, Allan N, Teive HA, et al. Huntington disease: DNA analysis in Brazilian population. Arq Neuropsiquiatr, 2000, 58: 977-985.
  • 4Rubinsztein DC, Leggo J, Coles R, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet, 1996, 59: 16-22.
  • 5McNeil SM, Novelletto A, Srinidhi J, et al. Reduced penetrence of the Huntington's disease mutation. Hum Mol Genet, 1997, 6: 775-779.
  • 6Ranen NG, Stine OC, Abbott MH, et al. Anticipation and instability of IT-15 (CAG)n repeat in parent-offspring paris with Huntington disease. Am J Hum Genet, 1995, 57: 593-602.
  • 7Kremer B, Almqvist E, Theilmann J, et al. Sex-dependent mechanisms for and contractions of the CAG repeat on affected Huntington disease chromosomes. Am J Hum Genet, 1995,57: 343-350.
  • 8Paulsen JS, Hoth KF, Nehl C, et al. Critical periods of suicide risk in Huntington's disease. Am J Psychiatry, 2005, 162: 725-731.
  • 9Zappacosta B, Monza D, Meoni C, et al. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease. Arch Neurol, 1996, 53: 493-497.
  • 10Brandt J, Folstein SE, Folstein MF. Differential cognitive impairment in Alzheimer' s disease and Huntington' s disease. Ann Neurol, 1988, 23 : 555-561.

共引文献4

同被引文献32

  • 1张宝荣,宋飞,殷鑫浈,夏昆,田均,黄鉴政,夏家辉.两个亨廷顿舞蹈病家系IT15基因的研究[J].遗传,2006,28(11):1345-1349. 被引量:4
  • 2Huntington' s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and un- stable on Huntington' s disease chromosomes [J]. Cell, 1993, 72(6) : 971-983.
  • 3Walker FO. Huntington' s disease [ J ]. Lancet, 2007,369 ( 9557 ) : 218-228.
  • 4The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group. ACMG/ASHG statement. Laboratory guidelines for Hunt- ington disease genetic testing[J]. Am J Hum Genet, 1998,62 (5) : 1243-1247.
  • 5Kutuev IA, Khusainova RI, Khidiyatova M, et al. Analysis of the IT15 gene in Huntington's disease families[J]. Russian J Genetics, 2004,40( 8 ) : 919-925.
  • 6Wexler NS. Venezuelan kindreds reveal that genetic and envi- ronmental factors modulate Huntington's disease age of onset [J]. Proc Natl Acad Sci USA, 2004,101 (10):3498-3503.
  • 7Rosenblatt A, Liang KY, Zhou H, et al. The association of CAG repeat length with clinical progression in Huntington dis- ease[J]. Neurology, 2006,66(7) : 1016-1020.
  • 8Djousse L, Knowhon B, Hayden MR, et al. Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16[J]. Neurogenetics, 2004,5(2) : 109-114.
  • 9Elahe TF, Carsten S, Stefan W, et al. Age at onset in Hunt- ington's disease: replication study on the associations of ADORA2A, HAP1 and OGGI[J]. Neurogenetics, 2010,11 (4) :435-439.
  • 10Silke M, Meiju S, Hong VC, et al. Age at onset in Hunting- ton's disease is modified by the autophagy pathway: implica- tion of the V471A pulymorph- hism in Atg7[J]. Hum Genet, 2010,128(4) :453-459.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部